Canbi Pharma Tech Limited
1206123-37-6 | Etrasimod

1206123-37-6 | Etrasimod

CAS:1206123-37-6
MF:C26H26F3NO3
MW:457.48
EINECS:
MDL No.:MFCD28502134

Send Inquiry
Description

Properties

Appearance White to khaki crystalline solid
Boiling point:621.4±50.0 °C
Density 1.326±0.06 g/cm3
 

Application:

Etrasimod is a new drug used to treat adult patients with moderate to severe active ulcerative colitis.

synthesis. The detailed information is shown in the following English table.

Category Details
Applications

1. Moderate-to-Severe Active Ulcerative Colitis: inducing and maintaining clinical remission by sequestering lymphocytes in lymph nodes, reducing intestinal inflammation.

2. Crohn's Disease: Investigated for moderate-to-severe active Crohn's disease (Phase III ongoing) to improve symptoms and endoscopic healing.

3. Atopic Dermatitis : Studied for moderate-to-severe atopic dermatitis to reduce pruritus and skin lesions (Phase II/III data positive).

4. Eosinophilic Esophagitis: Evaluated for reducing esophageal eosinophil infiltration and dysphagia (Phase II data available).

5. Alopecia Areata: Assessed for immune-mediated hair loss (early clinical data promising).

KSM Intermediates (Chemical Name, CAS No., Role)

1. 4-(Chloromethyl)-1-cyclopentyl-2-(trifluoromethyl)benzene (CAS 957208-65-0): Key starting material; provides the aryl chloromethyl group for O-alkylation with the indole core.

2. Ethyl 2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate (CAS 1206124-13-1): Core indole intermediate; undergoes O-benzylation with the aryl chloromethyl intermediate to form the ether linkage.

3. (R)-Ethyl 2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate (CAS 1206123-96-7): Chiral ester intermediate; hydrolyzed to the carboxylic acid (etrasimod free acid).

4. Etrasimod Free Acid (CAS 1206123-37-6): API free base; converted to etrasimod arginine salt (CAS 1206123-97-8) for formulation.

5. Etrasimod Arginine Salt (CAS 1206123-97-8): Pharmaceutical intermediate/formulation; improves solubility and bioavailability for oral administration.

 

Synonyms:

Etrasimod

1206123-37-6

APD334

etrasimodum

Velsipity

(R)-2-(7-((4-cyclopentyl-3-(trifluoromethyl)benzyl)oxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid

Etrasimod(APD334)

2-[(3R)-7-[[4-cyclopentyl-3-(trifluoromethyl)phenyl]methoxy]-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]acetic acid

CYCLOPENT(B)INDOLE-3-ACETIC ACID, 7-((4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)-1,2,3,4-TETRAHYDRO-, (3R)-

((3R)-7-((4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)PHENYL)METHOXY)-1,2,3,4-TETRAHYDROCYCLOPENTA(B)INDOL-3-YL)ACETIC ACID

2-((3R)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic acid

2-((3R)-7-((4-cyclopentyl-3-(trifluoromethyl)phenyl)methoxy)-1H,2H,3H,4H-cyclopenta(b)indol-3-yl)acetic acid

GTPL9331

 

 

Hot Tags: 1206123-37-6 | Etrasimod, China 1206123-37-6 | Etrasimod manufacturers, suppliers, api loyalty program api integration, api monetization strategies, api testing frameworks, api chatbot powered api integration, C62H86N12O16, Isoflurane

Inquiry
goTop

(0/10)

clearall